Scaffold osteocondrale trifasico per il trattamento dell’osteocondrite dissecante del ginocchio: Studio osservazionale

Title

Code

MAIOCD

Type

Osservazionale

Start Year

2022

Status

In Corso

Principal Investigator

+39-051-6366776

luca.andriolo@ior.it

Andriolo Luca, MD

2nd Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica II

Director

Zaffagnini Stefano, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta allo studio prot. MAIOCD

Tuesday 19 July 2022, 16:35

PG0005475_2022_ prot. MAIOCD.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Scaffold osteocondrale trifasico per il trattamento dell’osteocondrite dissecante del ginocchio: Studio osservazionale

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Scaffold osteocondrale trifasico per il trattamento dell’osteocondrite dissecante del ginocchio: Studio osservazionale

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in